FDA data Registry peer set 3 peers

Alternatives to aclidinium

3 same-class SPL records vs aclidinium - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Tudorza Pressair

Long-Acting Muscarinic Antagonist (LAMA) Prescription 3 alternatives found

3 Long-Acting Muscarinic Antagonist (LAMA) peers (wide set)

Compare aclidinium vs glycopyrrolate side-by-side →

aclidinium vs glycopyrrolate & tiotropium · FAERS reaction fields

FAERS top-reaction field "Difficulty breathing" shows the widest count spread between aclidinium and glycopyrrolate, tiotropium, umeclidinium in this extract (20,450-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect aclidinium glycopyrrolatetiotropiumumeclidinium
Difficulty breathing 1,869 - 22,319 -
Inhaler not working correctly 1,281 - - -
Skipped a dose of medicine 1,017 - - -
Asthma 814 793 10,817 604
Chronic obstructive pulmonary disease (COPD) 764 - - -
Purposely using the medicine wrong 741 - - -
Pneumonia 692 538 8,380 509
Cough 655 626 8,611 701

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

aclidinium peer mix vs class inventory

Peer mix

0 OTC and 3 Rx SPL records in this peer set (3 total). Class inventory for Long-Acting Muscarinic Antagonist (LAMA): 4 drugs.

Frequently Asked Questions

What same-class SPL records sit beside aclidinium?
This registry lists 3 Long-Acting Muscarinic Antagonist (LAMA) medication records beside aclidinium, including glycopyrrolate, tiotropium, umeclidinium. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Long-Acting Muscarinic Antagonist (LAMA) peer set (3 records)

aclidinium (Tudorza Pressair) sits in a wide Long-Acting Muscarinic Antagonist (LAMA) peer set (3 of 3 class peers shown).

Top FAERS reaction fields for aclidinium total 9,070 reports across 10 reactions, set beside glycopyrrolate, tiotropium, umeclidinium. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full aclidinium profile →

Field note for aclidinium: see also the generic vs brand label guide when reading Tudorza Pressair SPL strings.